aneurysms are probably slightly larger than 5.5 cm (by CT measurement) when the men are referred for treatment in NAAASP. If this policy is wrong, data accumulated by NAAASP and other screening programmes will soon start to show a significant rupture rate in men under surveillance. Although these are early days for the NHS Programme, there are no signs of that happening yet; should evidence come to light, then the Programme will consider changing its threshold for referral. In the meantime, NAAASP has the support of the Department of Health which is confident in the expectation that results similar to MASS can be achieved by a well run Programme.
The authors are right, however, to highlight variations in methodology used to measure aortic diameter. The aorta is unchanged whichever measuring method is used; however, different values may be recorded using ultrasound, CT or MRI. Sonographers and radiologists should consider reporting the method they use to measure aortic diameter, and as vascular surgeons, we should get used to clarifying that from radiology reports. From the perspective of a national programme, it is more important that everyone uses the same technique, than which technique is employed. All NAAASP technicians undergo formal training and accreditation, and regular ongoing quality assurance. The aim is to minimise the variation between technicians and surveillance visits. Perhaps vascular scientists outside NAAASP who regularly scan the aorta should consider moving to the ITI method, which has been shown to be reliable and reproducible. 3 
